Eiko Lifesciences Ltd

Wed 2/09/2026,16:1:0 | BSE : EIKO

₹46.25-0.78 (-1.66%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 47.94

Previous Close

₹ 47.03

Volume

12433

Mkt Cap ( ₹ Cr)

₹ 63.46

High

₹ 47.94

Low

₹ 45.50

52 Week High

₹ 64.44

52 Week Low

₹ 44.75

Book Value Per Share

₹ 50.75

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Eiko Lifesciences Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Eiko Lifesciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Eiko Lifesciences Q1 net profit jumps 53.62% at Rs 1.06 cr

    27 Aug 2026, 7:10PM The company reported standalone net profit of Rs 1.06 crore for the quarter ended June 30, 2026 as compared to Rs 0.69 crore in the same period last y

  • Eiko Lifesciences - Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations

    27 Aug 2026, 6:29PM The Company has sent a letter providing the weblink and QR Code for accessing the Notice convening the 49th Annual General Meeting (\AGM\) and the Ann

  • Eiko Lifesciences - Reg. 34 (1) Annual Report.

    24 Aug 2026, 8:41PM Pursuant to provision of Regulations 30 and 34 of the SEBI LODR Regulations, 2015, we wish to inform that the 49th Annual General Meeting of the Compa

  • Eiko Lifesciences - 49Th Annual General Meeting Of The Company Will Be Held On Tuesday, 22Nd Day Of September, 2026 At 04:00

    24 Aug 2026, 8:27PM Pursuant to provision of Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that

  • Eiko Lifesciences - Announcement under Regulation 30 (LODR)-Resignation of Director

    24 Aug 2026, 7:33PM The Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August, 2026, Board, inter-alia, considered the following:\r\n\r

  • Eiko Lifesciences - Announcement under Regulation 30 (LODR)-Change in Management

    24 Aug 2026, 7:24PM Appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) of the Company to hold the office up t

  • Eiko Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, 24Th August, 2026

    24 Aug 2026, 5:46PM Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August, 2026, Board, inter-alia, considered the following:\r\n1. Not

  • Eiko Lifesciences - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    18 Aug 2026, 7:00PM As per PDF attached.

  • Eiko Lifesciences - Announcement under Regulation 30 (LODR)-Allotment

    18 Aug 2026, 2:56PM Disclosure of Conversion of 305000 Warrants into Equity Shares belonging to Promoter and Non Promoter Category

  • Eiko Lifesciences - Board Meeting Outcome for Approved Un-Audited Standalone And Consolidated Financial Results For The Quart

    12 Aug 2026, 1:49PM Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

  • Eiko Lifesciences - Board Meeting Intimation for Meeting Scheduled To Be Held On 12Th August, 2026

    7 Aug 2026, 6:29PM Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider an

  • Eiko Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 5:00PM As of June 2026, 39.91% is owned by Indian Promoters and 60.09% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ei

  • Eiko Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    13 Jul 2026, 6:38PM Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Eiko Lifesciences Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 69.1732 58.1777 50.6783 29.4223 33.1827
Liabilities 69.1732 58.1777 50.6783 29.4223 33.1827
Equity 14.3459 13.7627 12.8728 8.3163 8.3163
Gross Profit 3.3368 1.7094 1.6127 0.9545 1.2953
Net Profit 3.5812 1.7408 0.7515 0.7688 0.7057
Cash From Operating Activities 6.9159 2.0461 -7.0797 4.2238 -7.7273
NPM(%) 8.5 5.35 2.69 4.19 2.77
Revenue 42.1268 32.4918 27.9293 18.3214 25.4119
Expenses 38.79 30.7824 26.3166 17.3669 24.1166
ROE(%) 5.14 2.5 1.07 1.1 1.01

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Eiko Lifesciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sugal and Damani Share Brokers Ltd 60.00 -3.23 16.44 28.94 66.05 1.67
360 One Wam Ltd 1170.00 -1.68 38.14 1880.25 2983.99 0.00
Arman Holdings Ltd 118.00 -0.67 36.99 24.12 18.24 0.00
Asia Capital Ltd 110.10 1.99 200.18 14.32 4.39 0.00

Company Info

Narendra Investments (Delhi) Limited, incorporated on 7th January 1977, is an Investment Company listed on the Ahmedabad Stock Exchange and Delhi Stock Exchange Ltd.MAIN OBJECTS OF THE COMPANYTo carry on the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest in any shares, bonds, stocks, obligations issued or guaranteed by any company constituted and carrying on business in India or elsewhere and debentures, debenture-stocks, bonds, obligations and securities issued or guaranteed by any Government, State, Sovereign, Commissioners Central or Provincial, public body or authority supreme, municipal, local or otherwise in India or elsewhere either out of its own funds or out of funds that it might borrow. 2016 -Listing of equity shares of Narendra Investments (Delhi) Ltd  2021 -Company name has changed to Eiko Lifesciences Ltd. from Narendra Investments (Delhi) Ltd..  2023 -The company issued rights shares of Rs. 10 in the ratio of 2:3 at a premium of Rs. 35 per share.  2024 -The Company entered into definitive business agreement with Vivacious Pharmatex Private Limited.

Narendra Investments (Delhi) Limited, incorporated on 7th January 1977, is an Investment Company listed on the Ahmedabad Stock Exchange and Delhi Stock Exchange Ltd.MAIN OBJECTS OF THE COMPANYTo carry on the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest in any shares, bonds, stocks, obligations issued or guaranteed by any company constituted and carrying on business in India or elsewhere and debentures, debenture-stocks, bonds, obligations and securities issued or guaranteed by any Government, State, Sovereign, Commissioners Central or Provincial, public body or authority supreme, municipal, local or otherwise in India or elsewhere either out of its own funds or out of funds that it might borrow. 2016 -Listing of equity shares of Narendra Investments (Delhi) Ltd  2021 -Company name has changed to Eiko Lifesciences Ltd. from Narendra Investments (Delhi) Ltd..  2023 -The company issued rights shares of Rs. 10 in the ratio of 2:3 at a premium of Rs. 35 per share.  2024 -The Company entered into definitive business agreement with Vivacious Pharmatex Private Limited.

Parent Organisation

Eiko Lifesciences Ltd.

Founded

07/01/1977

Managing Director

NSE Symbol

FAQ